Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 13

1.

Genetic basis for in vivo daptomycin resistance in enterococci.

Arias CA, Panesso D, McGrath DM, Qin X, Mojica MF, Miller C, Diaz L, Tran TT, Rincon S, Barbu EM, Reyes J, Roh JH, Lobos E, Sodergren E, Pasqualini R, Arap W, Quinn JP, Shamoo Y, Murray BE, Weinstock GM.

N Engl J Med. 2011 Sep 8;365(10):892-900. doi: 10.1056/NEJMoa1011138.

PMID:
21899450
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Daptomycin: a lipopeptide antibiotic for the treatment of serious Gram-positive infections.

Steenbergen JN, Alder J, Thorne GM, Tally FP.

J Antimicrob Chemother. 2005 Mar;55(3):283-8. Epub 2005 Feb 10. Review.

PMID:
15705644
[PubMed - indexed for MEDLINE]
Free Article
3.

Treatment options for vancomycin-resistant enterococcal infections.

Linden PK.

Drugs. 2002;62(3):425-41. Review.

PMID:
11827558
[PubMed - indexed for MEDLINE]
4.

Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens.

Carpenter CF, Chambers HF.

Clin Infect Dis. 2004 Apr 1;38(7):994-1000. Epub 2004 Mar 11. Review.

PMID:
15034832
[PubMed - indexed for MEDLINE]
Free Article
5.

[Role of daptomycin in the empirical and directed therapy of infections caused by Gram-positive bacteria in the critically ill patient].

Garnacho-Montero J, Amaya-Villar R, Gómez-Grande ML, Jerez V, Lorente-Ramos L, Loza A, Martínez A, Pozo JC, Sierra R, Pomares J, de la Torre MV, Ortiz C.

Rev Esp Quimioter. 2011 Mar;24(1):13-24. Review. Spanish.

PMID:
21412665
[PubMed - indexed for MEDLINE]
Free Article
6.

Daptomycin: a new treatment for insidious infections due to gram-positive pathogens.

Cottagnoud P.

Swiss Med Wkly. 2008 Feb 23;138(7-8):93-9. doi: 2008/07/smw-12045. Review.

PMID:
18293118
[PubMed - indexed for MEDLINE]
Free Article
7.

Clinical experience with daptomycin: bacteraemia and endocarditis.

Levine DP.

J Antimicrob Chemother. 2008 Nov;62 Suppl 3:iii35-39. doi: 10.1093/jac/dkn369. Review.

PMID:
18829724
[PubMed - indexed for MEDLINE]
Free Article
8.

[Bacteremia caused by vancomycin-resistant Enterococcus faecalis. Report of 2 cases].

Ortega L, Lite J, Garau J.

Enferm Infecc Microbiol Clin. 1991 Nov;9(9):547-50. Review. Spanish.

PMID:
1668361
[PubMed - indexed for MEDLINE]
9.

The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria.

Rybak MJ.

Clin Microbiol Infect. 2006 Mar;12 Suppl 1:24-32. Review.

PMID:
16445721
[PubMed - indexed for MEDLINE]
10.

Daptomycin: a rapidly bactericidal lipopeptide for the treatment of Gram-positive infections.

Kanafani ZA, Corey GR.

Expert Rev Anti Infect Ther. 2007 Apr;5(2):177-84. Review.

PMID:
17402833
[PubMed - indexed for MEDLINE]
11.

Daptomycin: a new drug class for the treatment of Gram-positive infections.

Alder JD.

Drugs Today (Barc). 2005 Feb;41(2):81-90. Review.

PMID:
15821781
[PubMed - indexed for MEDLINE]
12.

Emergence of daptomycin resistance following vancomycin-unresponsive Staphylococcus aureus bacteraemia in a daptomycin-naïve patient--a review of the literature.

van Hal SJ, Paterson DL, Gosbell IB.

Eur J Clin Microbiol Infect Dis. 2011 May;30(5):603-10. doi: 10.1007/s10096-010-1128-3. Epub 2010 Dec 30. Review.

PMID:
21191627
[PubMed - indexed for MEDLINE]
13.

Daptomycin in bone and joint infections: a review of the literature.

Rice DA, Mendez-Vigo L.

Arch Orthop Trauma Surg. 2009 Nov;129(11):1495-504. doi: 10.1007/s00402-008-0772-x. Epub 2008 Nov 7. Review.

PMID:
18989686
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk